Oncology Other

	11/12/2009	Non-AIDS-Defining Cancers in Patients with HIV Infection
	10/23/2009	Carcinoid Tumors of the Gastrointestinal Tract
	09/30/2009	Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
	09/22/2009	Multidisciplinary Approach to Management of Neuroendocrine Tumors
	09/08/2009	Cancer and Venous Thromboembolism: Current Clinical Issues
	08/17/2009	Questioning Clinical Assumptions in Accelerated-Phase and Blast-Crisis CML
	08/17/2009	How Can We Clarify Treatment Approaches in High-Risk CML?
	08/17/2009	How Can We Improve Treatment & Outcome in Blast-Crisis CML?
	08/12/2009	Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient?
	08/04/2009	Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
	08/04/2009	Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
	08/04/2009	Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer
	07/24/2009	Assessing the Safety and Efficacy of Emerging Therapies in Newly Diagnosed and Recurring Glioblastoma Multiforme: Latest Results From Orlando
	07/24/2009	Emerging Therapeutic Options in Newly Diagnosed GBM: Which Agents Show the Most Promise?
	07/24/2009	Finding the Right Targets and Treatments That Work: What Can We Learn From Recent Successes and Disappointments in Recurrent GBM?
	07/21/2009	Neoadjuvant Chemoradiotherapy for Esophageal Cancer, and Other Surgical Considerations
	07/16/2009	Achieving Optimal Management of High-Risk CLL
	07/16/2009	Selecting Treatment for an Adult Male Patient With CLL and High-Risk Cytogenetic Features
	07/16/2009	Managing an Elderly Male Patient With CLL Failing Initial Therapy
	07/15/2009	Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando
	07/15/2009	Changing Landscape of Treatment of Advanced RCC: What Are the Implications of the Latest Findings From Key First-Line Studies?
	07/15/2009	New Agents and Combinations for Advanced RCC: Taking Stock of the Latest Research
	07/09/2009	Exploring the Potential of Targeted Adjuvant Treatment and Individualized Therapy in Colorectal Cancer: Lessons from Orlando
	07/08/2009	Patient Scenarios for Everyday Practice: Managing Advanced HER2-Positive Breast Cancer Throughout the Disease Continuum
	07/08/2009	Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 1
	07/08/2009	Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 2
	07/02/2009	State of the Science in Multiple Myeloma: Which New Therapies Have Convincingly Demonstrated Improvements in Efficacy?
	07/02/2009	Assessing the Benefits of Novel Therapies in Newly Diagnosed Multiple Myeloma: Clinical and Research Implications of the Latest Trials
	07/02/2009	Assessing the Benefits of Novel Therapies in Relapsed/Refractory Multiple Myeloma: Clinical and Research Implications of Latest Trials
	06/25/2009	Practical Considerations in Management of Chronic Pain